As a non-surgical option, they provide a non-invasive method to address weight issues
These include premature ovarian insufficiency, surgical menopause following bilateral oophorectomy, chemotherapy-induced menopause, androgen deprivation therapy in prostate cancer patients, selective estrogen receptor modulators (SERMs) like tamoxifen, and certain medical conditions including hyperthyroidism and carcinoid syndrome
Plain formulation matters
Novo Nordisk the company that makes Ozempic and Wegovy has made clear it "does not directly or indirectly provide or sell bulk semaglutide to compounding pharmacies," and the FDA in January said it received reports of some compounders using salt forms of semaglutide, which is not the same active ingredient as the base form of semaglutide used in brand-name weight loss drugs
However, individual results depend on many factors including starting weight, compliance, and lifestyle habits